Skip to main navigation
Skip to search
Skip to main content
Providence Home
Search content at Providence
Home
Profiles
Research and Focus Areas
Grants and Projects
Research
Awards
Exploratory study of oral combination antiviral therapy for hepatitis C
Fred Poordad
, Eric Lawitz
, Kris V. Kowdley
, Daniel E. Cohen
, Thomas Podsadecki
, Sara Siggelkow
, Michele Heckaman
, Lois Larsen
, Rajeev Menon
, Gennadiy Koev
, Rakesh Tripathi
, Tami Pilot-Matias
, Barry Bernstein
Digestive Health
Oregon
Research output
:
Contribution to journal
›
Article
›
peer-review
274
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Exploratory study of oral combination antiviral therapy for hepatitis C'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Hepatitis C
100%
Ribavirin
100%
Antiviral Therapy
100%
Oral
100%
Ritonavir
75%
Infection
50%
Polymerase
50%
Hepatitis C Virus
50%
Proteinase Inhibitor
50%
Dabuzalgron
50%
Hepatitis C Virus Genotype 1
50%
Low Drug Dose
25%
Nausea
25%
Headache
25%
Virus RNA
25%
Liver Function Test
25%
Pruritus
25%
Liver Cirrhosis
25%
Dizziness
25%
Exanthem
25%
Peginterferon
25%
Interferon
25%
Adverse Event
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antiviral Therapy
100%
Ribavirin
100%
Hepatitis C
100%
Ritonavir
75%
Infection
50%
Hepatitis C Virus
50%
Hepatitis C Virus Genotype 1
50%
Proteinase Inhibitor
50%
Dabuzalgron
50%
Rash
25%
Adverse Event
25%
Liver Cirrhosis
25%
Nausea
25%
Pruritus
25%
Headache
25%
Dizziness
25%
Peginterferon
25%
Interferon
25%
Virus RNA
25%
Low Drug Dose
25%
Immunology and Microbiology
Hepatitis C
100%
Ribavirin
100%
Infectious Disease
50%
Hepatitis C Virus
50%
Hepatitis C Virus Genotype 1
50%
Infection
50%
Proteinase
50%
Protease
50%
Interferon Type I
25%
Low Drug Dose
25%
Pegylated Interferon
25%
Liver Function
25%
NS5B
25%
Ribonucleic Acid
25%
Cirrhosis
25%